XML 53 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 28,000 $ 76,101,000 $ (64,523,000) $ 11,606,000
Balance, shares at Dec. 31, 2018 28,392,853      
Common stock issued for directors fees 131,000 131,000
Common stock issued for directors fees, shares 147,830      
Costs related to issuance of stock   (58,000)   (58,000)
Stock Compensation Expense   233,000   233,000
Other Adjustments - Shares Issued, shares 144,899      
Other Adjustments - Fair Value allocation   (185,000) (185,000)
Net Income (Loss)     (923,000) (923,000)
Balance at Mar. 31, 2019 $ 28,000 76,222,000 (65,446,000) 10,804,000
Balance, shares at Mar. 31, 2019 28,685,582      
Balance at Dec. 31, 2019 $ 29,000 77,434,000 (67,257,000) 10,206,000
Balance, shares at Dec. 31, 2019 29,478,338      
Common stock issued for directors fees 55,000 55,000
Common stock issued for directors fees, shares 43,771      
Costs related to issuance of stock (145,000) (145,000)
Issuance of Common Stock $ 1,000 983,000 984,000
Issuance of Common Stock, shares 419,597      
Common Stock Issued for Convertible Notes 885,000 885,000
Common Stock Issued for Convertible Notes, shares 590,243      
Stock Compensation Expense 140,000 140,000
Net Income (Loss) 1,058,000 1,058,000
Balance at Mar. 31, 2020 $ 30,000 $ 79,352,000 $ (66,199,000) $ 13,183,000
Balance, shares at Mar. 31, 2020 30,531,949